Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported $53.39M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AbbVie USD 5.23B 400M Dec/2025
Actinium Pharmaceuticals USD 53.39M 6.54M Sep/2025
Amgen USD 9.13B 316M Dec/2025
Bioline Rx USD 7.91M 725K Sep/2025
Capricor Therapeutics USD 287.85M 268.34M Dec/2025
Pfizer USD 1.34B 295M Sep/2025